Medifast (MED) Operating Leases (2019 - 2026)

Medifast's Operating Leases history runs 8 years deep, the most recent figure standing at $16.1 million for Q1 2026.

• Quarterly Operating Leases rose 10.21% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 million (up 10.21% YoY) and the FY2025 annual result came in at $6.1 million, down 38.74% from the prior year.
• Operating Leases was $16.1 million for Q1 2026 at Medifast, up from $6.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $31.0 million in Q1 2022 and bottomed at $6.1 million in Q4 2025.
• A 5-year average of $17.3 million and a median of $18.3 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases soared 370.12% — and 2025, when it slumped 62.6%.
• Medifast's Operating Leases stood at $20.3 million in 2022, then fell by 20.46% to $16.1 million in 2023, then slumped by 38.35% to $9.9 million in 2024, then tumbled by 38.74% to $6.1 million in 2025, then jumped by 164.34% to $16.1 million in 2026.
• Business Quant data shows MED's Operating Leases at $16.1 million in Q1 2026, $6.1 million in Q4 2025, and $12.3 million in Q3 2025.